Come up with a name for your new list and we'll add to it:
Novan Therapeutics raised a round of funding on August 30, 2014. Investors include
Hatteras Venture Partners.
Novan is a clinical-stage drug development company aiming to commercialize nitric oxide-based products in selected therapeutic areas. The Company's core technologies solve the delivery issues with nit…